CA
NZ
UK
AU
IND
US
…
Pharmx Technologies Limited, together with its subsidiaries, engages in the technology and software development business in Australia and New Zealand. It offers Pharmx Gateway, an electronic ordering and invoicing solution; Pharmx Marketplace, an e-commerce ordering platform; and Pharmx Analytics, a solution that provides insights for suppliers and buyers. The company was formerly known as Corum Group Limited and changed its name to Pharmx Technologies Limited in October 2023. Pharmx Technologies Limited was incorporated in 1950 and is based in Sydney, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public disclosures for Pharmx Technologies Ltd (ASX:PHX) are limited and do not clearly state its operating business. If it operates in pharmaceutical or health technology, long-term drivers could include aging demographics and digital-health adoption, and investors may be interested if the company shows revenue traction and regulatory progress.
Principal risks are limited disclosure and an unclear business model, regulatory and clinical-development risk if active in healthcare, execution and commercialization risk, and likely need for additional capital.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -2.01M | 0.08M | 0.20M | -0.72M | 0.30M |
| Net income | -1.83M | -0.26M | -1.77M | -1.05M | 0.25M |
| Selling general administrative | - | 5.05M | 2.55M | 2.84M | 8.22M |
| Selling and marketing expenses | - | 0.35M | 0.22M | 0.17M | 0.26M |
| Gross profit | -0.07M | 5.96M | 5.25M | 4.81M | 10.52M |
| Reconciled depreciation | - | 1.28M | 1.20M | 0.99M | 2.17M |
| Ebit | -2.09M | 0.11M | 0.24M | -0.67M | 0.37M |
| Ebitda | -0.53M | 1.39M | 1.45M | 0.33M | 2.54M |
| Depreciation and amortization | 1.56M | 1.28M | 1.20M | 0.99M | 2.17M |
| Operating income | -2.09M | -1.42M | -1.36M | -0.67M | 0.37M |
| Other operating expenses | 9.71M | 8.74M | 7.85M | 7.08M | 13.74M |
| Interest expense | 0.04M | 0.03M | 0.04M | 0.05M | 0.07M |
| Tax provision | - | 0.34M | 0.11M | 0.16M | 0.28M |
| Interest income | - | 0.03M | 0.04M | 0.05M | 0.03M |
| Net interest income | - | 0.18M | 0.25M | 0.06M | -0.04M |
| Extraordinary items | - | 0.00M | -1.86M | -0.17M | 0.23M |
| Income tax expense | -0.19M | 0.34M | 0.11M | 0.16M | 0.28M |
| Total revenue | 7.62M | 7.32M | 6.49M | 6.02M | 11.92M |
| Total operating expenses | 2.02M | 7.38M | 6.62M | 5.87M | 12.34M |
| Cost of revenue | 7.69M | 1.36M | 1.23M | 1.21M | 1.40M |
| Total other income expense net | 0.08M | 1.50M | 1.56M | 0.29M | -0.07M |
| Discontinued operations | - | - | - | -0.17M | 0.23M |
| Net income from continuing ops | - | -0.26M | 0.10M | -0.88M | 0.02M |
| Net income applicable to common shares | - | -0.26M | -1.77M | -1.05M | 0.25M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 27.27M | 18.82M | 29.86M | 36.52M | 30.77M |
| Intangible assets | 9.64M | 9.68M | 10.81M | 11.24M | 18.61M |
| Other current assets | 2.13M | 0.10M | 0.08M | 7.18M | 1.70M |
| Total liab | 3.99M | 2.90M | 13.88M | 14.31M | 7.57M |
| Total stockholder equity | 23.28M | 15.93M | 15.97M | 22.21M | 23.20M |
| Other current liab | 1.15M | - | - | 10.67M | 3.89M |
| Common stock | 102.67M | - | - | 98.41M | 98.37M |
| Capital stock | - | 93.97M | 93.97M | 98.41M | 98.37M |
| Retained earnings | -80.11M | -78.29M | -78.02M | -76.25M | -75.20M |
| Other liab | - | - | - | 2.02M | 2.43M |
| Good will | 2.12M | 2.12M | 2.12M | 2.12M | 2.12M |
| Other assets | - | - | - | 0.53M | 0.85M |
| Cash | 2.57M | 4.17M | 13.14M | 12.81M | 5.76M |
| Total current liabilities | 3.22M | 1.73M | 11.95M | 12.29M | 5.11M |
| Current deferred revenue | - | - | - | 0.92M | 0.08M |
| Net debt | -2.03M | - | - | -12.77M | -5.43M |
| Short term debt | 0.28M | - | - | 0.03M | 0.30M |
| Short long term debt total | 0.54M | - | - | 0.03M | 0.33M |
| Other stockholder equity | - | - | - | 0.06M | 0.04M |
| Property plant equipment | - | - | - | 0.05M | 0.60M |
| Total current assets | 7.50M | 5.76M | 16.37M | 22.59M | 8.59M |
| Long term investments | - | - | - | - | 0.15M |
| Net tangible assets | - | - | - | 8.85M | 2.48M |
| Short term investments | - | - | - | 12.54M | 5.25M |
| Net receivables | 2.80M | 0.98M | 1.00M | 0.95M | 1.08M |
| Inventory | - | - | - | 0.00M | 0.04M |
| Accounts payable | 1.80M | 0.52M | 0.57M | 0.67M | 0.84M |
| Accumulated other comprehensive income | 0.72M | - | - | 0.06M | 0.04M |
| Non currrent assets other | 7.28M | 0.31M | 0.09M | - | - |
| Non current assets total | 19.77M | 13.07M | 13.49M | 13.93M | 22.18M |
| Capital lease obligations | - | 0.89M | 0.24M | 0.03M | 0.33M |
| Long term debt total | - | - | - | 0.00M | 0.02M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | -0.20M | 1.75M | -3.57M | -3.64M |
| Change to liabilities | - | - | - | 7.63M | -1.24M |
| Total cashflows from investing activities | -2.10M | - | 1.75M | -3.57M | -3.64M |
| Net borrowings | - | - | - | -0.31M | -0.32M |
| Total cash from financing activities | -0.32M | -0.14M | -4.62M | -0.33M | -0.36M |
| Change to operating activities | - | - | - | -0.07M | 1.08M |
| Net income | -1.83M | -0.26M | -1.77M | -1.05M | 0.02M |
| Change in cash | -1.60M | -8.96M | 0.33M | 7.05M | -0.72M |
| Begin period cash flow | 4.17M | 13.14M | 12.81M | 5.76M | 6.48M |
| End period cash flow | 2.57M | 4.17M | 13.14M | 12.81M | 5.76M |
| Total cash from operating activities | 0.82M | - | 3.21M | 10.94M | 2.19M |
| Depreciation | 1.56M | - | - | 0.75M | 2.17M |
| Other cashflows from investing activities | - | - | 3.33M | -0.21M | 0.34M |
| Dividends paid | - | - | - | - | 0.00M |
| Change to inventory | - | - | - | 0.03M | -0.01M |
| Change to account receivables | -0.87M | - | - | -0.07M | -0.22M |
| Sale purchase of stock | - | - | -4.49M | - | 0.00M |
| Other cashflows from financing activities | -0.29M | - | -0.02M | -0.33M | -0.36M |
| Change to netincome | - | - | - | 2.17M | 1.22M |
| Capital expenditures | 0.02M | 1.75M | 1.58M | 3.36M | 3.98M |
| Change in working capital | -0.96M | - | 2.01M | 10.13M | 1.97M |
| Other non cash items | 2.05M | - | - | - | -2.19M |
| Free cash flow | 0.81M | -9.88M | 1.62M | -3.36M | -1.78M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PHX Pharmx Technologies Ltd |
-0.00 5.80% |
0.07 | - | 11.79 | 6.06 | 1.95 | 5.69 | 92.17 |
| PME Pro Medicus Ltd |
-3.10 1.49% |
205.13 | 81.98 | 106.38 | 83.13 | 43.70 | 74.38 | 95.34 |
| 4DX 4DMEDICAL Ltd |
-0.13 5.39% |
2.28 | - | - | 205.57 | 8.53 | 170.03 | -7.29 |
| CGS Cogstate Ltd |
-0.09 2.66% |
3.29 | 33.80 | 27.86 | 9.59 | 6.95 | 6.35 | 19.27 |
| AYA ARTRYA Ltd |
- -% |
3.50 | - | - | 20505.14 | 7.00 | 16927.51 | 0.33 |
Pharmx Technologies Limited, together with its subsidiaries, engages in the technology and software development business in Australia and New Zealand. It offers Pharmx Gateway, an electronic ordering and invoicing solution; Pharmx Marketplace, an e-commerce ordering platform; and Pharmx Analytics, a solution that provides insights for suppliers and buyers. The company was formerly known as Corum Group Limited and changed its name to Pharmx Technologies Limited in October 2023. Pharmx Technologies Limited was incorporated in 1950 and is based in Sydney, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Nick England | Interim CEO & Exec. Chairman | NA |
| Ms. Zoe Hillier | Chief Financial Officer | NA |
| Mr. James Nevile | Chief Operating Officer | NA |
| Ms. Eryl Baron | Company Sec. | NA |
| Mr. Tom Culver | Chief Executive Officer | NA |
| Ms. Eryl Baron | Company Secretary | NA |
| Mr. Tom Culver | Chief Executive Officer | NA |
| Ms. Eryl Baron | Company Secretary | NA |
| Mr. Tom Culver | Chief Executive Officer | NA |
| Ms. Eryl Baron | Company Secretary | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...